Physician profile
Tracy Soledad
NPI 1508200353
$9,976.44
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $576 · 2021: $81.64 · 2022: $4,278 · 2023: $116 · 2024: $4,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,127 · Food and Beverage: $805 · Travel and Lodging: $567 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,126.90 |
| Food and Beverage | $804.67 |
| Travel and Lodging | $567.20 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,533.00 | 2022-2024 | |
| Tela Bio, INC. | $728.52 | 2019-2024 | Ovitex 2s |
| Davol INC. | $183.03 | 2019-2023 | Phasix Mesh |
| Stryker Corporation | $162.09 | 2019 | |
| Wound Management Technologies, INC | $89.04 | 2019 | |
| Allergan, INC. | $82.05 | 2021-2022 | |
| Kci USA, INC. | $36.75 | 2020-2021 | |
| Ethicon US, LLC | $31.84 | 2023 | Echelon Circular, Echelon Endopath |
| Teleflex LLC | $24.97 | 2023 | Quikclot |
| Astrazeneca Pharmaceuticals LP | $24.27 | 2023 | |
| Integra Lifesciences Corporation | $20.20 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $16.22 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Biom'Up France Sas | $15.98 | 2020 | |
| Tactile Systems Technology INC | $15.77 | 2022 | |
| Smith+Nephew, INC. | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Soledad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.